Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - perindopril erbumine -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - perindopril erbumine -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - perindopril erbumine -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - perindopril erbumine -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - perindopril erbumine, quantity: 8 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate - ozapace is indicated for: the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that ozapace be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients, it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials), who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - indapamide hemihydrate,perindopril erbumine -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 4 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; silica dimethyl silylate; lactose monohydrate - indopril 4 is indicated for: the treatment of hypertension.the treatment of heart failure. in such patients it is recommended that indopril 4 be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril tablets have not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; silica dimethyl silylate - indopril 2 is indicated for: the treatment of hypertension.the treatment of heart failure. in such patients it is recommended that indopril 2 be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril tablets have not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.